Harvest Fund Management Co. Ltd Invests $512,000 in HealthEquity, Inc. (NASDAQ:HQY)

Harvest Fund Management Co. Ltd acquired a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,334 shares of the company's stock, valued at approximately $512,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Holocene Advisors LP purchased a new stake in shares of HealthEquity in the 3rd quarter worth approximately $1,246,000. Loomis Sayles & Co. L P raised its stake in HealthEquity by 2.2% in the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock worth $92,216,000 after buying an additional 24,665 shares in the last quarter. HighTower Advisors LLC lifted its holdings in HealthEquity by 4.8% during the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after buying an additional 4,370 shares during the period. Geneva Capital Management LLC lifted its holdings in HealthEquity by 24.6% during the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after buying an additional 206,894 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in HealthEquity by 165.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company's stock valued at $1,673,000 after acquiring an additional 12,745 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is currently owned by insiders.

Remove Ads

HealthEquity Stock Performance

Shares of HealthEquity stock traded down $0.13 on Tuesday, reaching $90.19. 2,054,483 shares of the stock were exchanged, compared to its average volume of 697,297. The business has a 50 day moving average price of $104.67 and a two-hundred day moving average price of $95.84. The firm has a market capitalization of $7.80 billion, a price-to-earnings ratio of 82.74, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HQY. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target for the company. KeyCorp reduced their target price on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday. JMP Securities raised their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday. Finally, Royal Bank of Canada raised their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $113.31.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.